Miller Investment Management’s Citius Pharmaceuticals CTXR Stock Holding History

Miller Investment Management’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,986	Closed	-$49.9K	–	102
2024 Q3	$49.9K	Buy	3,986 +1,986	+99%	+$33.4K	0.01%	102
2024 Q2	$29.2K	Hold	2,000	–	–	﹤0.01%	103
2024 Q1	$44.9K	Hold	2,000	–	–	0.01%	104
2023 Q4	$37.8K	Hold	2,000	–	–	0.01%	101
2023 Q3	$34.2K	Hold	2,000	–	–	0.01%	96
2023 Q2	$60K	Hold	2,000	–	–	0.01%	95
2023 Q1	$58.5K	Hold	2,000	–	–	0.01%	94
2022 Q4	$39.5K	Hold	2,000	–	–	0.01%	94
2022 Q3	$61K	Hold	2,000	–	–	0.01%	90
2022 Q2	$46K	Hold	2,000	–	–	0.01%	90
2022 Q1	$90K	Hold	2,000	–	–	0.01%	96
2021 Q4	$77K	Hold	2,000	–	–	0.01%	96
2021 Q3	$102K	Hold	2,000	–	–	0.02%	89
2021 Q2	$174K	Hold	2,000	–	–	0.03%	80
2021 Q1	$89K	Hold	2,000	–	–	0.02%	79
2020 Q4	$51K	Buy	2,000 +1,000	+100%	+$26.1K	0.01%	77
2020 Q3	$26K	Buy	+1,000	New	+$28.3K	0.01%	69
2019 Q4	–	Sell	-800	Closed	-$15K	–	79
2019 Q3	$15K	Buy	+800	New	+$21.1K	﹤0.01%	77
2018 Q4	–	Sell	-1,600	Closed	-$68K	–	76
2018 Q3	$68K	Hold	1,600	–	–	0.02%	80
2018 Q2	$92K	Buy	+1,600	New	+$106K	0.03%	84

Other funds holding CTXR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWA

Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Miller Investment Management's CTXR Position: Q4 2024 in Review

Miller Investment Management sold out of Citius Pharmaceuticals (CTXR) in Q4 2024, closing a stake of 3,986 shares — an estimated $49.9K sold.

Miller Investment Management first reported a position in CTXR in Q2 2018 and held it in 20 quarters. The position peaked at $174K in Q2 2021. 30 funds tracked by Wall St. Rank hold CTXR as of Q4 2024.

Miller Investment Management reported no remaining Citius Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Miller Investment Management sold 3,986 Citius Pharmaceuticals shares in Q4 2024, an estimated $49.9K.
Miller Investment Management first reported a position in Citius Pharmaceuticals in Q2 2018 and held it in 20 quarters.
Miller Investment Management's Citius Pharmaceuticals position peaked at $174K in Q2 2021.
30 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2024.

Based on Miller Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.